SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Perkinelmer Inc – ‘8-K’ for 3/25/20

On:  Wednesday, 3/25/20, at 2:45pm ET   ·   For:  3/25/20   ·   Accession #:  1193125-20-84807   ·   File #:  1-05075

Previous ‘8-K’:  ‘8-K’ on / for 3/9/20   ·   Next:  ‘8-K’ on 4/1/20 for 3/26/20   ·   Latest:  ‘8-K’ on / for 2/1/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/25/20  Perkinelmer Inc                   8-K:7       3/25/20   11:182K                                   Donnelley … Solutions/FA

Current Report   —   Form 8-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     28K 
 6: R1          Document and Entity Information                     HTML     54K 
 9: XML         IDEA XML File -- Filing Summary                      XML     12K 
11: XML         XBRL Instance -- d908177d8k_htm                      XML     20K 
10: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 3: EX-101.DEF  XBRL Definitions -- pki-20200325_def                 XML     41K 
 4: EX-101.LAB  XBRL Labels -- pki-20200325_lab                      XML     67K 
 5: EX-101.PRE  XBRL Presentations -- pki-20200325_pre               XML     42K 
 2: EX-101.SCH  XBRL Schema -- pki-20200325                          XSD     17K 
 7: JSON        XBRL Instance as JSON Data -- MetaLinks               14±    22K 
 8: ZIP         XBRL Zipped Folder -- 0001193125-20-084807-xbrl      Zip     11K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX: 
  8-K  
 i PERKINELMER INC  i false  i 0000031791 0000031791 2020-03-25 2020-03-25 0000031791 pki:Commonstock1parvaluepershareMember 2020-03-25 2020-03-25 0000031791 pki:M1.875NotesDue2026Member 2020-03-25 2020-03-25 0000031791 pki:M0.600NotesDue2021Member 2020-03-25 2020-03-25

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM  i 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  i March 25, 2020

 

PerkinElmer, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

 i Massachusetts

 

 i 001-05075

 

 i 04-2052042

(State or Other Jurisdiction

of Incorporation or Organization)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 i 940 Winter Street,  i Waltham,  i Massachusetts

 

 i 02451

(Address of Principal Executive Offices)

 

(Zip Code)

Registrant’s telephone number, including area code:  i (781)  i 663-6900

Not applicable.

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

   i  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

   i  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

   i  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

   i  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

 i Common stock, $1 par value per share

 

 i PKI

 

 i The New York Stock Exchange

 i 1.875% Notes due 2026

 

 i PKI 21A

 

 i The New York Stock Exchange

 i 0.600% Notes due 2021

 

 i PKI 21B

 

 i The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  i 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

 

 


Item 7.01 Regulation FD Disclosure.

In response to anticipated investor questions regarding the press release issued by PerkinElmer, Inc. (the “Company”) on March 24, 2020 announcing the U.S. Food and Drug Administration’s Emergency Use Authorization (EUA) approval of the Company’s new Coronavirus RT-PCR test, the Company expects to provide information that to address growing supply constraints worldwide, it has expanded the production capacity of its extraction and RT-PCR tests at its global facilities and has the capability to ship millions of these solutions to its customers.    


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

PERKINELMER, INC.

             

Date: March 25, 2020

 

 

By:

 

/s/ Joel S. Goldberg

 

 

 

Joel S. Goldberg

 

 

 

Senior Vice President, Administration, General Counsel and Secretary


Dates Referenced Herein

This ‘8-K’ Filing    Date    Other Filings
Filed on / For Period end:3/25/20None on these Dates
3/24/20
 List all Filings 
Top
Filing Submission 0001193125-20-084807   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Mar. 28, 3:59:22.1pm ET